Skip to main content

Table 1 Baseline of distal metastasis in a patient with cholangiocarcinoma

From: Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study

Characteristics

level

No(N = 324)

Yes(N = 21)

p

status (%)

alive

178 (54.9)

4 (19.0)

0.003

 

dead

146 (45.1)

17 (81.0)

 

times (mean (SD))

NA

16.46 (12.92)

7.99 (6.20)

0.003

AFPL3.AFP (mean (SD))

NA

0.10 (0.09)

0.17 (0.11)

0.002

Bile duct dilation (%)

no

260 (80.2)

12 (57.1)

0.025

 

yes

64 (19.8)

9 (42.9)

 

gender (%)

female

62 (19.1)

9 (42.9)

0.02

 

male

262 (80.9)

12 (57.1)

 

differentiation (%)

moderately differentiated

262 (80.9)

11 (52.4)

0.002

 

Poorly differentiated

55 (17.0)

10 (47.6)

 
 

well differentiated

7 (2.2)

0 (0.0)

 

hypertension (%)

no

287 (88.6)

13 (61.9)

0.001

 

yes

37 (11.4)

8 (38.1)

 

CA199.G (%)

<39

202 (62.3)

2 (9.5)

<0.001

 

>1000

58 (17.9)

8 (38.1)

 
 

39-1000

64 (19.8)

11 (52.4)

 

P (mean (SD))

NA

1.62 (4.77)

64.91 (286.00)

<0.001

number (%)

Double

76 (23.5)

4 (19.0)

0.844

 

single

248 (76.5)

17 (81.0)

 

cholestol (mean (SD))

NA

4.27 (1.29)

3.63 (0.84)

0.026

Margin invasion (%)

no

136 (42.0)

19 (90.5)

<0.001

 

yes

188 (58.0)

2 (9.5)

Â